Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...
Our team at the UK Dementia Research Institute’s Biomarker Factory at UCL are part of the global effort working to develop ...
Tech advances already show a future of testing in which we might not have to suffer and die while waiting for systems that ...
Assessing the toxicity of food contaminants—including carcinogenic potential—is a major challenge in evaluating the risks ...
AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely ...
In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
ROCHESTER, Minn. — Vyriad, a gene therapy company based in Rochester, has raised $85 million to support its new VV-169 cancer treatment which will begin human testing this year. The treatment aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results